Published October 20, 2021 | Version v1
Journal article Open

Enhanced medical diagnosis for dOCTors: a perspective of optical coherence tomography

Description

Significance: After three decades, more than 75,000 publications, tens of companies being involved in its commercialization, and a global market perspective of about USD 1.5 billion in 2023, optical coherence tomography (OCT) has become one of the fastest successfully translated imaging techniques with substantial clinical and economic impacts and acceptance.

Aim: Our perspective focuses on disruptive forward-looking innovations and key technologies to further boost OCT performance and therefore enable significantly enhanced medical diagnosis. Approach: A comprehensive review of state-of-the-art accomplishments in OCT has been performed.

Results: The most disruptive future OCT innovations include imaging resolution and speed (single-beam raster scanning versus parallelization) improvement, new implementations for dual modality or even multimodality systems, and using endogenous or exogenous contrast in these hybrid OCT systems targeting molecular and metabolic imaging. Aside from OCT angiography,
no other functional or contrast enhancing OCT extension has accomplished comparable clinical and commercial impacts. Some more recently developed extensions, e.g., optical coherence elastography, dynamic contrast OCT, optoretinography, and artificial intelligence enhanced OCT are also considered with high potential for the future. In addition, OCT miniaturization for portable, compact, handheld, and/or cost-effective capsule-based OCT applications, home-OCT, and self-OCT systems based on micro-optic assemblies or photonic integrated circuits will revolutionize new applications and availability in the near future. Finally, clinical translation of OCT including medical device regulatory challenges will continue to be absolutely essential.

Conclusions: With its exquisite non-invasive, micrometer resolution depth sectioning capability, OCT has especially revolutionized ophthalmic diagnosis and hence is the fastest adopted imaging technology in the history of ophthalmology. Nonetheless, OCT has not been completely exploited and has substantial growth potential — in academics as well as in industry. This applies not only to the ophthalmic application field, but also especially to the original motivation of OCT to enable optical biopsy, i.e., the in situ imaging of tissue microstructure with a resolution approaching that of histology but without the need for tissue excision.

Files

Enhanced medical diagnosis for dOCTors a perspective of optical coherence tomography.pdf

Additional details

Funding

European Commission
ESOTRAC - Hybrid optical and optoacoustic endoscope for esophageal tracking. 732720
European Commission
HandheldOCT - Handheld optical coherence tomography 871312
European Commission
FBI - Multimodal, Functional Bio-Photonic Imaging 721766
European Commission
MOON - Multi-modal Optical Diagnostics for Ocular and Neurodegenerative Disease 732969
European Commission
REAP - Revealing drug tolerant persister cells in cancer using contrast enhanced optical coherence and photoacoustic tomography 101016964
European Commission
PROSCOPE - Point-of-care instrument for diagnosis and image-guided intervention of Colo-Rectal Cancer 871212
European Commission
SWIMMOT - Switchable magneto-plasmonic contrast agents and molecular imaging technologies 899612
European Commission
OCTCHIP - Ophthalmic OCT on a Chip 688173
European Commission
PHAST - Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy 860185
European Commission
MIB - Multi-modal, Endoscopic Biophotonic Imaging of Bladder Cancer for Point-of-Care Diagnosis 667933
FWF Austrian Science Fund
Tomography across the Scales F 68
European Commission
SkinOptima - Link Skin Morphology and Vasculature with Diseases using Optical Imaging 894325